Estate Counselors, LLC Vertex Pharmaceuticals Inc Transaction History

Estate Counselors, LLC

  • $346 Million
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 08, 2023
BUY
$285.76 - $321.48 $555,803 - $625,278
1,945 New
1,945 $561,000
Q2 2020

Aug 07, 2020
SELL
$225.48 - $295.8 $475,762 - $624,138
-2,110 Closed
0 $0
Q1 2020

Apr 28, 2020
BUY
$199.77 - $247.81 $421,514 - $522,879
2,110 New
2,110 $502,000

Others Institutions Holding VRTX

# of Institutions
1,717
Shares Held
226M
Call Options Held
1.19M
Put Options Held
1.56M
View Full List

About VERTEX PHARMACEUTICALS INC

VRTX Quotes by TradingView
  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $133B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Estate Counselors, LLC Portfolio

Follow Estate Counselors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Estate Counselors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Estate Counselors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email